Novartis AG - 26 Year Stock Price History | NVS

Historical daily share price chart and data for Novartis AG since 1996 adjusted for splits. The latest closing stock price for Novartis AG as of August 18, 2022 is 84.92.
  • The all-time high Novartis AG stock closing price was 93.75 on April 11, 2022.
  • The Novartis AG 52-week high stock price is 94.26, which is 11% above the current share price.
  • The Novartis AG 52-week low stock price is 79.09, which is 6.9% below the current share price.
  • The average Novartis AG stock price for the last 52 weeks is 85.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Novartis AG Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2022 85.7595 84.3355 93.7500 80.1100 84.9200 1.15%
2021 83.8541 87.2319 91.3130 76.4941 83.9515 -3.82%
2020 80.2655 84.6429 88.2622 65.3246 87.2874 3.41%
2019 76.4414 65.7930 85.0174 65.7930 84.4112 25.68%
2018 64.3994 63.9741 71.6397 56.6981 67.1627 5.88%
2017 60.5243 53.1155 65.4624 51.0734 63.4302 19.40%
2016 55.6572 60.2544 60.9045 49.2939 53.1228 -12.13%
2015 68.0733 63.0471 74.5679 58.9966 60.4582 -4.53%
2014 59.9103 52.0597 66.0542 51.7158 63.3273 19.13%
2013 48.0868 40.6710 53.1641 40.5882 53.1575 31.80%
2012 36.4157 35.4852 40.7539 32.8019 40.3333 15.67%
2011 34.7870 34.6456 39.3521 31.5024 34.8692 1.14%
2010 30.8609 29.6815 34.9556 25.6041 34.4760 12.27%
2009 25.0458 26.7644 31.6843 19.1595 30.7083 14.23%
2008 27.7512 28.6419 32.9882 23.6904 26.8833 -5.69%
2007 29.0511 29.9461 30.9828 27.0831 28.5055 -3.65%
2006 28.9726 27.0859 31.5428 26.7321 29.5856 11.29%
2005 25.0856 25.0297 27.7090 23.1752 26.5844 5.64%
2004 22.8353 22.4527 25.2040 20.5635 25.1641 12.10%
2003 19.0499 17.8037 22.4478 15.6442 22.4478 27.36%
2002 18.6777 16.9512 21.0333 16.2455 17.6261 1.96%
2001 18.0738 20.9336 21.0224 15.6203 17.2875 -17.31%
2000 16.8455 16.3604 20.9056 13.4661 20.9056 26.91%
1999 17.6279 23.0256 23.2481 15.7127 16.4728 -24.44%
1998 18.9766 18.1699 22.4138 16.0735 21.8021 21.46%
1997 15.5031 11.8250 18.6397 11.3076 17.9493 50.81%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $188.558B $52.877B
Novartis has one of the strongest and broadest portfolio of oncology drugs and generics. It continues to build depth in 5 core therapeutic areas Cardio-Renal, Immunology, Neuroscience, Oncology and Hematology, strength in technology platforms - Targeted Protein Degradation, Cell Therapy, Gene Therapy, Radioligand Therapy, and xRNA. Novartis efforts to strengthen its wide and deep oncology portfolio by developing breakthrough treatments. Cosentyx, Entresto, Kesimpta, Zolgensma, Kisqali and Leqvio. In March 2015, Novartis acquired certain oncology products and pipeline compounds from Glaxo. In exchange, it sold its non-influenza Vaccines business to Glaxo. Also, the company has spun off the Alcon business into a separate company. In January 2015, Novartis divested its Animal Health division to Lilly. In July 2015, the company divested its influenza vaccines business to CSL Limited. Novartis has also acquired The Medicines Company, adding Leqvio, to its portfolio. Novartis sold its investment in Roche.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $440.598B 16.77
Eli Lilly (LLY) United States $301.034B 38.17
Pfizer (PFE) United States $276.521B 8.10
AbbVie (ABBV) United States $250.080B 10.63
Novo Nordisk (NVO) Denmark $237.182B 31.29
Merck (MRK) United States $230.630B 12.04